Herbas VPB

Print
EN | LT
LT - COMBINATIONS OF ANTI-4-1BB ANTIBODIES AND ADCC-INDUCING ANTIBODIES FOR THE TREATMENT OF CANCER
EN - COMBINATIONS OF ANTI-4-1BB ANTIBODIES AND ADCC-INDUCING ANTIBODIES FOR THE TREATMENT OF CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28
A61K 39/395
A61P 35/00
European patent
(11) Number of the document 2699598
(13) Kind of document T
(96) European patent application number 12713849.3
Date of filing the European patent application 2012-04-09
(97) Date of publication of the European application 2014-02-26
(45) Date of publication and mention of the grant of the patent 2019-03-06
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2012/032704
Date 2012-04-09
PCT application publication
(87) Number WO 2012/145183
Date 2012-10-26
Priority applications
(30) Number Date Country code
201161477153 P 2011-04-19 US
Inventors
(72)
ELLIOTT, Mark William, US
FISHER, Timothy Scott, US
SHARP, Leslie Lynne, US
Grantee
(73) Pfizer Inc., 235 East 42nd Street, New York, NY 10017, US
Title
(54) COMBINATIONS OF ANTI-4-1BB ANTIBODIES AND ADCC-INDUCING ANTIBODIES FOR THE TREATMENT OF CANCER
  COMBINATIONS OF ANTI-4-1BB ANTIBODIES AND ADCC-INDUCING ANTIBODIES FOR THE TREATMENT OF CANCER
Last update date 2021-04-30